Impact of a clinical decision support tool on prediction of progression in early-stage dementia: a prospective validation study-Reference-Cited by-同舟云学术

Impact of a clinical decision support tool on prediction of progression in early-stage dementia: a prospective validation study

Published:2019-03-20 Issue:1 Volume:11 Page:
ISSN:1758-9193
Container-title:Alzheimer's Research & Therapy
language:en
Short-container-title:Alz Res Therapy

Author:

Bruun Marie^ORCID,Frederiksen Kristian S.,Rhodius-Meester Hanneke F. M.,Baroni Marta,Gjerum Le,Koikkalainen Juha,Urhemaa Timo,Tolonen Antti,van Gils Mark,Rueckert Daniel,Dyremose Nadia,Andersen Birgitte B.,Lemstra Afina W.,Hallikainen Merja,Kurl Sudhir,Herukka Sanna-Kaisa,Remes Anne M.,Waldemar Gunhild,Soininen Hilkka,Mecocci Patrizia,van der Flier Wiesje M.,Lötjönen Jyrki,Hasselbalch Steen G.

Funder

European Commission

Publisher

Springer Science and Business Media LLC

Subject

Cognitive Neuroscience,Neurology (clinical),Neurology

Link

http://link.springer.com/content/pdf/10.1186/s13195-019-0482-3.pdf

Reference44 articles.

1. Mitchell AJ, Beaumont H, Ferguson D, et al. Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: meta-analysis. Acta Psychiatr Scand. 2014;130:439–51.

2. Visser PJ, Verhey F, Knol DL, et al. Prevalence and prognostic value of CSF markers of Alzheimer’s disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study. Lancet Neurol. 2009;8:619–27 https://doi.org/10.1016/S1474-4422(09)70139-5 .

3. Jessen F, Amariglio RE, Van Boxtel M, et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer’s disease. Alzheimers Dement. 2014;10:844–52. https://doi.org/10.1016/j.jalz.2014.01.001 .